2 Patents
- US124484552025Combination Therapies with Bispecific Anti-egfr/c-met Antibodies and Third Generation EGFR Tyrosine Kinase Inhibitors
Janssen Biotech, Inc.
0 cites - US118790132024Combination Therapies with Bispecific Anti-egfr/c-met Antibodies and Third Generation EGFR Tyrosine Kinase Inhibitors
JANSSEN BIOTECH, Inc.
0 cites